Compare

Jyong Biotech Ltd. vs Emmaus Life Sciences, Inc. vs Gain Therapeutics, Inc. vs Clene Inc.

Latest annual figures from SEC filings. Each company is shown for its own most recent fiscal year, so period ends can differ. Select a figure to see its full history.

Latest fiscal yearJyong Biotech Ltd.
MENS
Emmaus Life Sciences, Inc.
EMMA
Gain Therapeutics, Inc.
GANX
Clene Inc.
CLNN
Year ended2025-12-312025-12-312025-12-312025-12-31
Revenuen/a$12.45Mn/a$200.0K
Revenue growth (YoY)n/a-25.2%n/a-41.5%
Gross marginn/a93.1%n/a78.5% (computed)
Operating marginn/a1.9%n/an/m
Net marginn/a-60.2%n/an/m
Net income-$4.67M-$7.49M-$20.16M-$26.17M
EPS (Diluted)-$0.06-$0.12-$0.61n/a
Operating cash flow-$3.04M-$11.0K-$18.47M-$18.55M
Free cash flown/a-$12.0Kn/a-$18.59M
Cash & equivalentsn/a$2.13M$20.84M$5.19M
Total assets$20.78M$21.44M$22.82M$18.13M
Total liabilities$45.68M$85.04M$4.25M$35.72M
Shareholders' equity-$24.91M-$63.61M$18.56M-$17.59M
Return on year-end equityn/an/a-108.6%n/a
Shares outstanding76.03M70.19M42.07M10.85M

n/a means the company did not report that line under the concept TickerFacts maps, not that it is zero.

Revenue, most recent five fiscal years

Fiscal yearJyong Biotech Ltd.Emmaus Life Sciences, Inc.Gain Therapeutics, Inc.Clene Inc.
Latestn/a$12.45M
Ended 2025-12-31
$55.2K
Ended 2023-12-31
$200.0K
Ended 2025-12-31
1 year earliern/a$16.65M
Ended 2024-12-31
$140.1K
Ended 2022-12-31
$342.0K
Ended 2024-12-31
2 years earliern/a$29.60M
Ended 2023-12-31
$165.0K
Ended 2021-12-31
$654.0K
Ended 2023-12-31
3 years earliern/a$18.39M
Ended 2022-12-31
$28.9K
Ended 2020-12-31
$473.0K
Ended 2022-12-31
4 years earliern/a$20.61M
Ended 2021-12-31
n/a$723.0K
Ended 2021-12-31